Trial Profile
An Open-label, Randomized, Cross-over, Active-controlled Study to Evaluate the Efficacy and Safety of Meptin Swinghaler and Berotec N Metered Aerosol in Mild to Moderate Stable Asthma Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jan 2013
Price :
$35
*
At a glance
- Drugs Procaterol (Primary) ; Fenoterol
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 New trial record